
Program Layout
Track 1: Cancer Diagnostics
WCC 101: Prognostic and Predictive Biomarkers
WCC 102: Next-Generation Cancer Imaging
WCC 103: Liquid Biopsies
Track 2: Anti-Cancer Drug Discovery and Development
WCC 201: New Anti-Cancer Drug Discovery, Design, and Optimization
WCC 202: Innovation and Biomarkers in Cancer Drug Development
WCC 203: Anticancer Drugs from TCM and Natural Products
Track 3: Clinical Oncology
WCC 301: Cancer of the Reproductive System
WCC 302: Breast Cancer
WCC 303: Lung Cancer/Other Thoracic Cancers
WCC 304: Cancer of Digestive System
WCC 305: Head and Neck Tumors
WCC 306: Skin Cancer
WCC 307: Hematologic Malignancies
Track 4: Cancer Therapy & Treatments
WCC 401: Cancer Targeted Therapy
WCC 402: Robotic & Surgical Therapy
WCC 403: Combination Therapy, Complementary and Alternative Medicine
Track 5: Oncology Nursing and Care
WCC 501: Cancer Rehabilitation, Cancer Nursing and Care
WCC 502: Palliative & Critical Care
Track 6: Cancer Epidemiology and Prevention
WCC 601: Cancer Epidemiology and Novel Risk and Causative Factors
WCC 602: Cancer Screening and Healthy Living
![]() |
Speaking Proposals Are Now Being Accepted |
![]() |
Call for Exhibitors and Sponsors |
![]() |
Call for Collaborative |

Dr. Vladimir Lazar
Chief Scientific and Operating Officer
WIN Consortium, France

Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA
©2016-2023 All right reserved by BIT Congress Inc. Tel: 0086-411-84799609, Fax: 0086-411-84796897 |